Advertisement
Survey Series
Institutions
For Advertisers
|
|
||||
|
Taking Stock
The debate continues on whether new rules for stock options are good or bad for US biotechs
Email: Clare Kittredge - ckittredge@the-scientist.com The Scientist 2005, 19(5):38
|
||||
|
|
||||
|
When Human Genome Sciences in Rockville, Md., recruits top scientists, the biotechnology company usually offers them a stake in its future success in the form of stock options. "We very aggressively use stock options to attract talent to our industry, because we have to compete with the much more stable pharmaceutical industry, or government or university research labs, where job security is so much greater," says Alain Cappeluti, vice president of finance at the 13-year-old company.
|
|
|||||||||
|
|||||||||
|
